2Deepa R , Shanthi RS , Premalatha G, et al. Comparison of ADA 1997 and WHO criteria for diabetes in south Indians the Chennai Urban Population Study. American Diabetes Associa- tion. Diabet Med , 2000, 17:872-874.
3Bao YQ, Ma XJ. Glycated haemoglobin Alc for diagnosing dia- betes in Chinese population., cross sectional epidemiological sur- vey. BMJ, 2010, 340:c2249.
4Ameriean Diabetes Association. Standards of medical care in diabetes-2010[J]. Diabetes Care, 2010, 33(3) :S11-S61.
5PetitClerc C, Solberg HE. Approved recommendation ( 1987 ) onthe theory of reference values. Part 2. Selection of individuals for theproduction of reference values [J]. J Clin Chem Clin Biochem,1987,25( 9) : 639-644.
6NCCLS C28-A2 , How to define and determine reference intervals inthe clinical laboratory. 2nd edition. Approved Guideline[ S]. Nation-al Committee for Clinical Laboratory Standards, 2000.
7CLSI EP15-A2 , User demonstration of performance for precision andaccuracy [ S]. Clinical and Laboratory Standards Institute,2004.
8Pani LN, Korenda L, Meigs JB, et al. Effect of aging on Ale levelsin individuals without diabetes: evidence from the Framingham Off-spring Study and the National Health and Nutrition Examination Sur-vey2001-2004[J]. Diabetes Care, 2008,31(10) :1991-1996.
9Qiao Q, Tuomilehto J, Baikau B, et al. Are insulin resistance, im-paired fasting glucose and impaired glucose tolerance all equallystrongly related to age? [ J ]. Diabetic Med, 2005 , 22 ( 11 ):1476-1481.
10Rhee MK, Ziemer DC , Kolm P, et al. Postchallenge glucose riseswith increasing age even when glucose tolerance is normal[ J]. Dia-betic Med, 2006’ 23(11):1174-1179.
8Pajunen P, Peltonen M, Eriksson JG, et al. HbAle in diagno- sing and predicting type 2 diabetes in impaired Glucose toler- ance: the Finnish Diabetes Prevention Study. Diabet Med, 2011,28: 36-42.
9Herder C, Kolb H, Koenig W, et al. Association of systemic concentrations of maerophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes. Diabetes Care, 2006,29 : 368-371.
10Zhang H,Wei J, Xue R, et al. Berberine lowers blood Glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism, 2010,59 : 285-292.
